Labeler · US market
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. is a US drug labeler with US FDA registrations covering 25 drug concepts (24 currently active) across 115 packages. It is currently the only active US supplier of 18 drugs.
ACTIVE - US
openFDA · updated weekly
Labeler codes0597
Active drugs24
Registrations63 active / 66
Packages115
Sole supplier of18 drugs
No company profile yet
FDA filings tell us what Boehringer Ingelheim Pharmaceuticals, Inc. registers, not who it is. If you know this company - what it makes, who owns it, where it manufactures - you can add it. Every submission is reviewed before it goes live.
Submit information about this company →Portfolio25 drugs · US
Every drug concept this labeler has US registrations for, by package count.
| Drug | Type | NDCs | Packages | Status |
|---|---|---|---|---|
| Adalimumab-Adbm kit | rx | 12 | 12 | SUPPLYING |
| Empagliflozin, Metformin Hydrochloride tablet, extended release | rx | 4 | 10 | SUPPLYING |
| Empagliflozin And Metformin Hydrochloride tablet | rx | 4 | 9 | SUPPLYING |